A Report on Non-Ionizing Radiation

2015 Articles

Skirts Freedom of Information Act

November 30, 2015
Last updated December 1, 2015

NIEHS really doesn’t want to talk about it. Ten years into a $25+ million project to assess the cancer risk of wireless radiation in laboratory animals, the staff at the National Institute of Environmental Health Sciences remains tight-lipped and refuses to release project documents.

NIEHS has many reasons for keeping a low profile. The RF project, the most expensive in National Toxicology Program history, is years late and two-to-three times over budget. A more immediate concern is that it could force the institute into a position it would desperately prefer to avoid: Being at the center of the ever-contentious controversy over cell phone radiation and cancer.

NY Times Tech Columnist Has Hands Slapped

March 20, 2015
Last updated April 19, 2015

The New York Times went into damage control mode yesterday after Nick Bilton, a tech columnist and a rising star at the newspaper, suggested that precaution is the best approach to the use of cell phones and wearable electronics.

No sooner had Bilton’s column hit print than Margaret Sullivan, the Times’ Public Editor, chastised Bilton for his naive analysis. (It was posted on the Web a day earlier.) Sullivan targeted the lack of “sophisticated evaluation of serious research.”

Germany’s Alex Lerchl Does a U-Turn

March 13, 2015
Last updated March 14, 2015

The RF–cancer story took a remarkable turn a few days ago. A new animal study challenged many of the assumptions which lie at the heart of claims that RF radiation —whether from cell phones, cell towers or Wi-Fi— are safe.

The new study, from Germany, a replication of an earlier experiment, also from Germany, found that weak cell phone signals can promote the growth of tumors in mice. It used radiation levels that do not cause heating and are well below current safety standards. Complicating matters even further, lower doses were often found to be more effective tumor promoters than higher levels; in effect, turning the conventional concept of a linear dose-response on its head.